Graybill Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
2017
Q2
$1.95M Sell
2017
Q1
$2.44M Buy
2016
Q4
$2.63M Buy
2016
Q3
$2.7M Sell
2016
Q2
$2.47M Buy